INS and Hyperglycemia: T1DM affects roughly 5–10% of all diabetes patients and is characterized by the death of pancreatic insulin-producing β-cells destroyed by the immune system, resulting in an extreme shortage of insulin, hyperglycemia, inflammation, oxidative damages and other metabolic problems [6,7].